// App-Quantinova.ai

: Examination of resistance to nivolumab monotherapy through single-cell analysis of tumors from patients enrolled in the HCRN GU16-260 study of nivolumab monotherapy.

Researchers

Presenter

  • David A. Braun

Principal Investigators

  • Kelly Street

  • Opeyemi Jegede

  • Neil Ruthen

  • Miya Hugaboom

  • Nicholas R Schindler

  • David F. McDermott

  • Elizabeth R. Plimack

  • Jeffrey A. Sosman

  • Naomi B. Haas

  • Michael E. Hurwitz

  • Hans J. Hammers

  • Sabina Signoretti

  • Michael B. Atkins

  • Catherine J. Wu

Medical Centers

  • Keck School of Medicine of USC, Los Angeles, CA

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Brigham and Women's Hospital, Brookline, MA

  • Yale University School of Medicine, New Haven, CT

  • Dana-Farber Cancer Institute, Boston, MA

  • Fox Chase Cancer Center, Temple Health, Philadelphia, PA

  • University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA

  • Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC

  • Northwestern University, Chicago, IL

  • UTSouthwestern Medical Center, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • X-Ray Repair Cross Complementing 1

  • T-cell receptor

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved